Biodegradable IR-1061 Nanoparticles for Deep NIR-II In Vivo Imaging

Study Background and Research Question

Near-infrared (NIR) fluorescence bioimaging has become increasingly important in biomedical research due to its superior tissue penetration and low phototoxicity compared to ultraviolet or visible light-based probes. However, many existing fluorescent dyes for biomedical research, such as those excited by UV or short-wavelength visible light, suffer from limited penetration and higher phototoxicity. The NIR region, especially over 1000 nm (NIR-II, or the 'second biological window'), enables more effective deep tissue imaging, making it an attractive target for developing advanced optical imaging probes. Despite advances using inorganic nanomaterials like quantum dots and rare-earth nanoparticles, concerns regarding their synthesis complexity and clinical safety have driven the search for safer, easier-to-prepare alternatives. The core research question addressed in the reference study is: Can a simple, biocompatible, and biodegradable nanoparticle system be developed to stably encapsulate an over-1000 nm near infrared fluorescent dye (specifically, IR-1061) for deep in vivo imaging applications?

Key Innovation from the Reference Study

The primary innovation of the study lies in formulating a straightforward, one-pot encapsulation method for loading the hydrophobic, poorly water-soluble IR-1061 dye into biodegradable polymeric micelles based on PEG-b-PCL. Unlike previous strategies requiring multi-step synthesis, layer-by-layer assembly, or complex nanomaterial fabrication, this method leverages the amphiphilic nature of PEG-b-PCL to form micelles with a hydrophobic core, which efficiently incorporates IR-1061. Both the dye and the copolymer are commercially available, which makes the process accessible and reproducible across research labs. The resulting nanoparticles—termed OTN-PNPs—offer stable NIR-II emission in aqueous environments and are designed for optimal blood circulation and eventual renal clearance due to their biodegradable composition and size control. This innovation potentially lowers the barrier to entry for researchers seeking robust fluorescent dyes for in vivo imaging, particularly in translational or preclinical studies.

Methods and Experimental Design Insights

The authors used an amphiphilic block copolymer, poly(ethylene glycol)-block-poly(ε-caprolactone) (PEG-b-PCL), to self-assemble into micelles in water. IR-1061, a small-molecule NIR-II dye with a cyanine or thiopyrilium structure and poor water solubility, was encapsulated into the hydrophobic core via a simple mixing protocol. This encapsulation strategy is critical because, while IR-1061 can be dissolved in water at low concentrations, it fails to remain dispersed at higher concentrations due to aggregation and precipitation. The micellar system overcomes this limitation, facilitating stable dispersion and emission in biological media.

Key aspects of the experimental design include:

• Optimization of nanoparticle size (10–100 nm range) to exploit the enhanced permeability and retention (EPR) effect for tumor accumulation and avoid undesired rapid clearance or immune trapping.
• Use of biodegradable and biocompatible polymer to ensure post-imaging safety via hydrolytic degradation and renal clearance.
• Assessment of NIR-II fluorescence properties and in vivo imaging capacity in animal models.

Core Findings and Why They Matter

The encapsulated IR-1061 nanoparticles demonstrated strong NIR-II fluorescence in aqueous environments, maintaining stability and brightness suitable for deep tissue imaging. In vivo studies highlighted the ability of these nanoparticles to circulate in blood for extended periods, accumulate at tumor sites via the EPR effect, and subsequently degrade for renal clearance. Notably, the preparation was reportedly simple and reproducible, making it more accessible than metal-based or inorganic alternatives.

This work is significant for several reasons:

• It provides an effective method to use low-molecular-weight near infrared fluorescent dyes for in vivo imaging, overcoming the water solubility barrier that has limited their application in biological systems.
• Biodegradable polymer carriers reduce long-term toxicity concerns compared to inorganic nanoparticles, supporting the translational potential of NIR-II imaging probes.
• By simplifying nanoparticle preparation, the method accelerates workflow adoption in labs without advanced nanochemistry infrastructure.

Comparison with Existing Internal Articles

Several recent studies and practical guides have expanded on the application and optimization of IR-1061 as a near infrared fluorescent dye for in vivo imaging:

• Yu et al. demonstrated the use of H-aggregated IR-1061 in liposomal nanosystems, achieving enhanced NIR-II fluorescence and photothermal therapy. While their approach focused on tumor-targeted synergistic therapy, the current reference paper's key contribution is a more generalizable, biodegradable micellar delivery system for imaging alone.
• The article "IR-1061: Enabling Precision NIR-II Imaging in Nanocatalytic Therapy" analyzes the integration of IR-1061 with nanozyme platforms for cancer therapy, highlighting the versatility of IR-1061 in molecular imaging. However, the reference study emphasizes simplicity and clinical safety via polymeric encapsulation.
• Recent work on polymer microenvironments showed that the chiral structure of hydrophobic polymers can influence IR-1061’s fluorescence properties, underlining the importance of polymer selection for probe stability—consistent with the PEG-b-PCL approach in the reference study.

Together, these resources illustrate the rapid evolution of IR-1061 probe technology for deep tissue imaging, with the present study filling a key gap in easy-to-prepare, biodegradable, and biocompatible nanoparticle design.

Limitations and Transferability

While the presented one-pot micelle formulation is practical and improves biocompatibility, some limitations remain:

• The stability and performance of IR-1061-loaded micelles in highly complex in vivo environments require further validation, particularly under pathological conditions with altered clearance mechanisms.
• Encapsulation efficiency and release kinetics may be affected by variations in PEG-b-PCL molecular weight and formulation parameters, necessitating further optimization for specific biomedical applications.
• Clinical translation will depend on comprehensive long-term toxicity and clearance studies, which are beyond the scope of the initial work.

Despite these limitations, the simple encapsulation strategy is readily adaptable to other hydrophobic near infrared fluorescent dyes, potentially broadening its impact in molecular imaging research.

Protocol Parameters

• Micelle preparation: Dissolve PEG-b-PCL and IR-1061 in a common organic solvent (e.g., DMSO), then add to water under stirring for one-pot self-assembly.
• Encapsulation ratio: Adjust the mass ratio of polymer to dye to optimize loading and minimize aggregation; typical starting ratios are 10:1 (w/w).
• Particle size control: Tune polymer and solvent concentrations to achieve 10–100 nm hydrodynamic diameter for optimal blood circulation and EPR effect.
• Purification: Remove free dye and solvent by dialysis or ultrafiltration before in vivo use.
• Imaging window: Excite at wavelengths suitable for NIR-II emission (typically 1064 nm for IR-1061), and collect emission above 1000 nm for deep tissue imaging.

Outlook: Implications for Molecular Imaging

The demonstration of a simple, biodegradable, and biocompatible nanoparticle system for encapsulating IR-1061 marks an important step toward more accessible and safer deep tissue imaging technologies. By lowering technical barriers and addressing safety issues associated with inorganic nanoparticles, the approach supports broader adoption in research and preclinical settings. Future work will likely focus on further optimizing nanoparticle stability, investigating long-term clearance, and extending the strategy to other NIR-II dyes as supported by the polymer microenvironment studies.

Research Support Resources

To facilitate similar in vivo imaging workflows, researchers may use IR-1061 (SKU C8242), a near infrared fluorescent dye provided by APExBIO, which is optimized for OTN-NIR imaging applications and is compatible with DMSO-based encapsulation protocols. The product's documentation provides solubility and handling guidance to ensure reproducible nanoparticle preparation. For further application-specific insights, consult peer-reviewed articles and practical workflow guides addressing IR-1061 deployment in advanced molecular imaging contexts.